Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06130735 · ClinicalTrials.gov registry record · NA

Impact of Intensive Computerized Cognitive Training

A NA study of Mild Cognitive Impairment and Acquired Brain Injury, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06130735: Recruiting NA study of Mild Cognitive Impairment and Acquired Brain Injury, sponsored by Brigham and Women's Hospital.

NCT06130735 is a NA study of Mild Cognitive Impairment and Acquired Brain Injury that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 30 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06130735, a NA study of Mild Cognitive Impairment and Acquired Brain Injury, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To investigate factors that predict cognitive enhancement following engagement in an intensive Computerized Cognitive Training Protocol.

Primary Outcome

We will use age-corrected standard scores of the NIH toolbox Total Cognitive Composite, Fluid Intelligence Composite, and individual scores on RAVLT, Verbal Fluency, and Trailmaking Task as cognitive outcome measures.

Conditions Studied

Mild Cognitive Impairment Acquired Brain Injury Mild Neurocognitive Disorder

Interventions

  • BEHAVIORAL Cognitive Computerized Training

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-10-01
Est. Completion 2026-03-01
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT06130735 shows while recruiting

NCT06130735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Computerized Training is the first listed.

NCT06130735 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06130735 about?

NCT06130735 is a clinical study titled "Impact of Intensive Computerized Cognitive Training". To investigate factors that predict cognitive enhancement following engagement in an intensive Computerized Cognitive Training Protocol.

What is the current status of trial NCT06130735?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-10-01. Estimated completion is 2026-03-01.

What conditions does trial NCT06130735 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Acquired Brain Injury, Mild Neurocognitive Disorder.

What interventions are being tested in trial NCT06130735?

The interventions under investigation include: Cognitive Computerized Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06130735?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06130735 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06130735's enrollment target sits among peer trials

30 166th of 205 higher than 37 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06130735

Source: ClinicalTrials.gov NCT06130735, the US trial registry maintained by the National Library of Medicine. NCT06130735 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.